Davide Leone & Partners Investment CO Ltd. Incyte Corp Transaction History

Davide Leone & Partners Investment CO Ltd.

  • $0
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$79.87 - $87.53 $1.65 Million - $1.81 Million
-20,673 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$80.74 - $97.7 $1.67 Million - $2.02 Million
20,673 New
20,673 $1.8 Million
Q1 2020

May 15, 2020
SELL
$63.18 - $85.97 $23.6 Million - $32.1 Million
-373,387 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$72.82 - $86.52 $26 Million - $30.9 Million
-356,566 Reduced 48.85%
373,387 $27.7 Million
Q1 2019

May 15, 2019
BUY
$63.56 - $88.17 $46.4 Million - $64.4 Million
729,953 New
729,953 $62.8 Million

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Davide Leone & Partners Investment CO Ltd. Portfolio

Follow Davide Leone & Partners Investment CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email